quest diagnost lean narrow moat weather
updat forecast estim jun
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jun
estim jun
price data jun
rate updat jun
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
posit lead provid
independ diagnost test build network
patient servic center across countri
think quest size cost advantag allow benefit
sever secular trend includ prolifer diagnost test
greater clinic
addit expect longer term reimburs
pressur push hospital-bas lab small independ
outsourc volum largest lowest-cost produc
relianc person
quest primari nation competitor labcorp domin
independ diagnost test landscap thank vast nation
network laboratori two firm creat barrier
entri gener substanti cost advantag region
hospit lab industri seen steadi consolid
compani acquir smaller competitor recent
quest focus establish presenc hospital-bas
lab either oper consult basi contrast
portfolio
higher-margin esoter test acquisit ameripath
athena celera
histor pattern expand
importantli quest benefit key trend includ greater
activ manag care steer insur lower-cost lab
penetr high-deduct plan increas presenc
retail
despit quest formid size attract cost structur
firm histor trail peer labcorp oper effici
diagnost busi think firm recent shift toward
work hospital-bas lab could hamper effici even
due higher cost structur latter nonetheless
quest still reliabl gener econom profit underscor
strength moat current manag team spent
four year focus on-going integr acquisit
play catch-up oper front streamlin
organ greater effici final begun see
result turnaround effort profit growth
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
lead independ provid diagnost test
inform servic compani gener
revenu clinic test anatom patholog esoter test
substanc abus test nation network patient servic
center firm also run diagnost solut segment provid
clinic trial test risk assess servic inform technolog
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
stand behind fair valu estim per
share incorpor impact medicar clinic
lab fee schedul reimburs cut expect
pama-l cut continu appli pressur
last year first three-year cycl
reset rate base case assum quest
medicar revenu subject maximum
cut expans
definit applic lab place next cycl
set reimburs anticip medicar
reimburs rate moder two year
continu expect gradual volum gain healthcar
util resum volum final stabil late
seen gradual steadi growth sinc
macroeconom condit eas healthcar util
gradual recov think compani focu
esoter test pay segment return
mid-single-digit growth
pharmaceut biotech compani aim
person target therapi expect steadi
stream new biomark discoveri greater applic
molecular diagnost across clinic spectrum
bode well quest anticip growth higher-margin
complex test partial off-set price pressur
routin test overal think oper margin includ
depreci grow mid- high teen
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest
best-cas scenario assum esoter test
prove stronger expect see averag annual
revenu growth next five year mix shift drive
volum price gain outperform adjust
medicar clinic lab fee schedul favor
expect greater-than-expect effici
realiz non-traditional allianc hospital-bas
lab case rais fair valu estim
bear-cas scenario project weaker util
maximum cut medicar clinic lab fee schedul
longer term translat averag annual
growth anatom patholog growth remain
flat in-sourc continu slowli esoter test
revenu growth exceed firm
benefit oper leverag product mix turn
unfavor headwind would translat
oper margin hover averag put
fair valu estim per share
quest enjoy narrow moat part duopoli
domin independ refer lab market compar
hospital-bas lab smaller region player
quest typic offer signific cost advantag thank
scale volum exampl test hospit lab
typic cost time averag test
quest advantag becom evid
throughput increas translat high oper
leverag addit firm nationwid footprint
extens network patient servic center
in-physician offic servic would difficult replic
scratch quest advantag cost structur
nation coverag also appeal payer
structur reimburs polici funnel patient
larg independ lab payer would typic rather
negoti largest refer lab includ quest
provid best geograph coverag insur
instead cobbl togeth market-by-market
coverag multipl smaller region lab final
quest scale reach make attract partner
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
includ autom
integr autom
quest one key challeng maintain moat
continu lower cost structur quest key lever
endeavor
technolog consolid lab facil
meantim expect quest continu snap smaller
competitor
oper think firm like moder
acquisit larger target offer higher-margin
complex test capabl work integr
sizabl purchas alreadi made recent quest
pursu opportun manag hospital-bas
lab type arrang
econom attract wholesal purchas
non-inpati
non-outpati yet clear much influenc
competit quest labcorp remain ration
point think irrat price unlik long
higher-pr rival like hospit constitut primari
competit payer continu focu reduc usag
higher-pr diagnost lab quest labcorp
like benefit exampl follow
impend expir long-term
exclus contract labcorp largest privat payer
contract quest labcorp effort
drive insur lowest-cost produc
final think opportun industri
horizon move away
volume-bas
reimburs could posit independ
diagnost lab healthcar reform shepherd
reimburs valu instead volum think
opportun diagnost firm captur
valu histor elud industri industri
estim diagnost test account less total
research invent variou diagnost test
distribut channel sell test
hold quest moat trend stabl larg
weak util rel well key trend
diagnost lab market add favor condit
independ lab specif new experi among
payer push financi risk onto provid made
doctor hospit price-sensit come
lab test dynam put end
encroach hospital-affili lab quest
labcorp busi hospital-bas lab
gain market share independ thank
gener reimburs polici favor hospit
set concurr move toward hospit
purchas physician practic direct test
hospit lab trend hospit pull back
invest lab reli independ lab
outsourc test also mean primari
advantag largest independ refer lab -- lower
cost -- grow relev practition payer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
healthcar spend influenc approxim
treatment decis industri demonstr
valu think quest competitor could captur
larger portion healthcar pie
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oadvanc technolog person medicin
increas number complex esoter
gene-bas test avail patient test
gener carri higher profit margin quest
oquest activ seek hospital-outreach
program roll acquisit offer
attract econom quest
organ patient record lab test inform
databas doctor use
like refer patient quest facil
oquest
oper
ineffici current manag team
yet fulli turn around oper
oquest previou strateg foray indian
market anim health disappoint
ultim kept manag focus
improv oper quest mainstay routin
esoter test segment
oon anecdot basi consist heard
complaint patient poor servic quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
even roll-up strategi quest maintain manag
balanc sheet activ contribut rise debt
leverag earli sinc firm deleverag
repay debt expand profit
march long-term debt stood billion time
ebitda over firm gener kept debt/ebitda
time rang manag aim
beyond quest recent de-lever matur schedul
look manag near term exist cash
million march avail credit facil
due within next five year million due
million due sinc estim quest
abl gener roughli million annual free cash
flow averag next five year think
problem meet oblig
especi take measur approach share
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest quest
hospital-bas lab firm may abl realiz
mani oper effici roll hospit
outreach program could pose difficulti quest
enhanc profit think grow relianc
duplic test fall health system reli
proprietari electron medic record keep independ
lab favor intern hospital-bas lab lower
price larg insur would lead smaller profit
quest labcorp quest consist eke
oper effici firm could see
profit buckl pressur payer
new cut medicar clinic lab fee schedul
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
test mean
reset cycl significantli sever
expect guidelin
left
hospital-bas lab equat calcul market
reimburs rate aggreg influenc
outsiz way quest labcorp -- two
lowest-cost produc diagnost lab industri
seen actual impact cut show
take long enlarg pool lab
includ next cycl reimburs adjust
take place mani healthcar situat
must balanc goal lower cost
object patient access expect medicar
reimburs pressur continu
eas second cycl start still think
quest benefit either rise reimburs
rate hospital-bas
lab smaller
independ lab decid shift volum quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ceo/chairman board/
repres date owner name posit common share held report holder issuer
share
fund
share
fund
manag turnov think quest
becom focus capital-alloc decis
recent introduc number improv make
govern shareholder-friendli applaud
compani design jenn britel non-execut
chairman board also like inclus tim
ring retir ceo cr bard board long
admir ring team disciplin prudent
deploy capit
quest adopt annual elect director
instead stagger three-year term previous
place quest shift away bonu target tie
earn per share toward metric includ revenu
growth return invest capit realiz cost
effici believ compani past use stock
option compens excess
particularli hope dynam chang
current manag -- ceo steve rusckowski award
nearli million stock option award first
year quest anoth million year sinc
final think would like see manag
director take larger equiti stake firm execut
offic director less stock
past particularli impress
firm record capit alloc mainli
cohes strategi guid invest
howev rusckowski leadership quest
focus acquir stand-alon lab special
esoter diagnost hospit outreach program
think move reinforc quest moat
broaden firm menu test increas test
volum ultim contribut firm attract
cost structur howev wari firm effort
move deepli less-tradit arrang
hospital-bas lab manag oper
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
higher-cost asset appear
manag display innov vision
seen rival labcorp anticip emerg
like genom scienc value-bas
reimburs could significantli reshap
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fair valu estim apr
post first-quart result gener
met expect stand firm fair
valu estim overal quest saw mix bag factor
incorpor estim full year
expect pama-l reimburs pressur
continu exert expect
let next three-year cycl set
medicar clinic lab fee schedul begin roll
hand quest organ volum growth
first quarter respect perspect
believ volum continu grow
longer term continu think quest rival labcorp
largest lowest-cost produc best
posit weather medicar cut gain scale
industri consolid progress ultim trend
solidifi quest narrow econom moat
wide expect chose quest
non-exclus prefer network lab provid
time end contract higher-cost lab
quest also confirm suspicion firm avoid
signific price concess weve seen past
switch quest labcorp
decad ago see evid
payer less interest squeez price
lowest-cost produc play
interest increas access quest
labcorp offer nation scope expens
aim tap ream diagnost data quest
labcorp amass part larger effort better
manag patient outcom value-bas reimburs
take hold think trove diagnost data
extrem compel unitedhealth optum unit
alreadi analyz treatment outcom data manag
cost heighten qualiti
thu surpris payer follow
path pave includ aetna horizon
cross shield new jersey cross
shield georgia anticip trend toward non-
exclus contract benefit quest labcorp
offer widespread access lower cost
also intrigu trident file chapter
view canari coal mine come
pama cut trident major diagnost lab
signific presenc nurs home long-term care
sub-seg market independ lab serv
custom typic receiv total revenu
medicar stark contrast quest
receiv less revenu directli
medicar wouldnt surpris see
independ lab substanti medicar exposur
close next two year quest labcorp
unlik pursu new sourc volum
subsequ loss access underscor second
thought trade-off zeal institut
pama-l cut
quest diagnost wrap full year close
expect chang fve feb
quest diagnost post fourth-quart full-year
result gener met mute expect
project fall within rang manag
outlook leav fair valu estim unchang
first year medicar clinic lab fee
schedul cut behind us becom clear
magnitud reimburs reduct driven
protect access medicar act turn
significantli larger industri center
medicar medicaid servic anticip
take step moder effect includ
larg proport hospital-bas lab next data
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
collect report period began jan
within diagnost lab industri continu think
largest labsquest labcorp sonic enjoy narrow
econom moatsar better posit weather
period intens reimburs pressur nonetheless
see consider impact pama lowest-
cost produc difficult imagin impact must
significantli greater higher-cost lab
fourth-quart volum solid organ
struck declin revenu per
requisitionth largest declin weve seen last
decad quest rev-per-req significantli wors
rival labcorp fourth quarter declin partial
relat time collect account receiv although
quest manag indic pama cut major
factor declin point mix shift payer denial
patient price concess skeptic pama
cut werent driver overal labcorp better job
manag quarterli rev-per-req declin basi
point pama reduc number basi point
partial off-set favor test mix
plan keep eye dynam quest adjust
expect accordingli unfold
rule unconstitut district court
near-term impact fundament dec
dec judg reed connor northern district
texa issu rule effect declar patient
protect afford act
unconstitut assum littl chang
compani cover healthcar sector
near term rule like make way
appeal process surpris see
case third appear make front
 suprem court potenti timelin final
basi decis find root congress
elimin shared-respons financi penalti
accompani passag tax cut job act
late last year short judg connor found individu
mandat essenti insever provis
congress decis elimin enforc
tax penalti law render entireti
legisl unconstitut logic follow
 suprem court decis upheld
constitut congress power taxat
view healthcar provid sector at-risk
stem chang prevail healthcar
legisl whether chang individu coverag
roll-back medicaid expans higher uninsur
rate unequivoc equat pressur hospit margin
payer perspect trade-off littl less clear
although medicaid-focus insur like feel
bulk enrol loss
intend make chang moat rate fair
valu estim result decis continu
monitor case make way appel
court come month outcom timelin
uncertain make meaning chang
assumpt earli day addit wildcard
potenti legisl action muddi
ultim financi penalti carri
insur coverag set end jan
understand feder govern intend
maintain statu quo appeal process
insur alreadi lock rate propos
earliest like see potenti effect
rule premium polici offer slate
open enrol season
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
